Life Science Leader
Michigan No Longer A Safe Haven For Pharmaceutical Companies?
April 17, 2024
Pharmaceutical companies may soon face more product liability litigation in Michigan after the state repealed its unique Drug Immunity Law. The Drug Immunity Law passed in 1995 provided an absolute defense for pharmaceutical companies in product liability suits stemming from the safety and efficacy of their drug products. Michigan reportedly had the only law in the nation that shielded drug manufacturers and sellers from such liability. This article addresses the impact of this change to Michigan’s law.
This article first appeared on Life Science Leader. View the article here.
Contacts
Capabilities
Suggested News & Insights
The Nonprofit Boardroom: Current Issues, Considerations, and Emerging RisksWednesday, November 4, 2026Revised EU Product Liability Directive: The Long Read — Scope, Key Changes, and Compliance Implications for Businesses (Part 1)October 21, 2026Sidley Represents Strategic Partnership Between Silgan and AIP in US$7.3 Billion Transaction to Create Diversified Global Metal Packaging BusinessOctober 19, 20262026 Momentum Food and Beverage ExchangeOctober 6-7, 2026And Now a Word From the Panel: Accessing Key MDL DataSeptember 23, 2026Sidley Represents Vi-Jon in Chapter 11 CaseSeptember 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory